Helen M. Thackray
2017 - GlycoMimetics
In 2017, Helen M. Thackray earned a total compensation of $934.5K as Chief Medical Officer at GlycoMimetics, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $197,904 |
|---|---|
| Option Awards | $320,250 |
| Salary | $412,300 |
| Other | $4,050 |
| Total | $934,504 |
Thackray received $412.3K in salary, accounting for 44% of the total pay in 2017.
Thackray also received $197.9K in non-equity incentive plan, $320.3K in option awards and $4.1K in other compensation.
Rankings
In 2017, Helen M. Thackray's compensation ranked 9,285th out of 14,666 executives tracked by ExecPay. In other words, Thackray earned more than 36.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,285 out of 14,666 | 37th |
Division Manufacturing | 3,569 out of 5,772 | 38th |
Major group Chemicals And Allied Products | 1,224 out of 2,075 | 41st |
Industry group Drugs | 984 out of 1,731 | 43rd |
Industry Pharmaceutical Preparations | 773 out of 1,333 | 42nd |
Source: SEC filing on April 13, 2018.
Thackray's colleagues
We found three more compensation records of executives who worked with Helen M. Thackray at GlycoMimetics in 2017.